应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
AVXL Anavex Life Sciences Corp.
交易中 12-23 13:52:15 EST
11.29
+2.66
+30.87%
最高
11.50
最低
8.92
成交量
561.07万
今开
8.97
昨收
8.63
日振幅
29.90%
总市值
9.58亿
流通市值
9.28亿
总股本
8,480万
成交额
6,040万
换手率
6.83%
流通股本
8,221万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Anavex Life Sciences 2024年第四季度GAAP每股收益$(0.14),优于预期$(0.16);现金为1.322亿美元
财报速递 · 12-23 20:34
Anavex Life Sciences 2024年第四季度GAAP每股收益$(0.14),优于预期$(0.16);现金为1.322亿美元
Anavex Life Sciences Corp.盘中异动 早盘快速拉升17.61%报10.15美元
市场透视 · 12-23 22:35
Anavex Life Sciences Corp.盘中异动 早盘快速拉升17.61%报10.15美元
异动解读 | Anavex Life Sciences财报亏损好于预期 股价盘中大涨15.87%
异动解读 · 12-23 22:34
异动解读 | Anavex Life Sciences财报亏损好于预期 股价盘中大涨15.87%
异动解读 | Anavex Life Sciences盘前大涨9.85%,财报亏损好于预期
异动解读 · 12-23 20:36
异动解读 | Anavex Life Sciences盘前大涨9.85%,财报亏损好于预期
Anavex Life Sciences Corp.盘中异动 下午盘股价大跌5.10%
市场透视 · 12-19
Anavex Life Sciences Corp.盘中异动 下午盘股价大跌5.10%
Anavex Life Sciences Corp.盘中异动 早盘股价大涨5.08%
市场透视 · 12-16
Anavex Life Sciences Corp.盘中异动 早盘股价大涨5.08%
Anavex Life Sciences Corp.盘中异动 早盘股价大涨5.12%报8.73美元
市场透视 · 12-13
Anavex Life Sciences Corp.盘中异动 早盘股价大涨5.12%报8.73美元
Anavex Life Sciences Corp.盘中异动 股价大涨5.18%
市场透视 · 12-10
Anavex Life Sciences Corp.盘中异动 股价大涨5.18%
Anavex Life Sciences Corp.盘中异动 早盘股价大涨5.26%报8.00美元
市场透视 · 12-06
Anavex Life Sciences Corp.盘中异动 早盘股价大涨5.26%报8.00美元
Anavex Life Sciences Corp.盘中异动 股价大跌5.04%
市场透视 · 12-03
Anavex Life Sciences Corp.盘中异动 股价大跌5.04%
Anavex Life Sciences Corp.盘中异动 早盘股价大涨5.23%报9.96美元
市场透视 · 12-02
Anavex Life Sciences Corp.盘中异动 早盘股价大涨5.23%报9.96美元
Anavex Life Sciences Corp.盘中异动 早盘股价大涨5.04%
市场透视 · 11-29
Anavex Life Sciences Corp.盘中异动 早盘股价大涨5.04%
Anavex Life Sciences Corp.盘中异动 早盘快速拉升6.92%报9.74美元
市场透视 · 11-25
Anavex Life Sciences Corp.盘中异动 早盘快速拉升6.92%报9.74美元
Anavex Life Sciences Corp.盘中异动 股价大涨5.10%
市场透视 · 11-20
Anavex Life Sciences Corp.盘中异动 股价大涨5.10%
Anavex Life Sciences Corp.盘中异动 股价大跌5.92%报7.56美元
市场透视 · 11-16
Anavex Life Sciences Corp.盘中异动 股价大跌5.92%报7.56美元
Anavex Life Sciences Corp.盘中异动 早盘急速下跌5.23%
市场透视 · 11-14
Anavex Life Sciences Corp.盘中异动 早盘急速下跌5.23%
Anavex Life Sciences Corp.盘中异动 早盘股价大涨6.06%报9.80美元
市场透视 · 11-11
Anavex Life Sciences Corp.盘中异动 早盘股价大涨6.06%报9.80美元
Anavex Life Sciences Corp.盘中异动 急速上涨5.17%报8.03美元
市场透视 · 11-08
Anavex Life Sciences Corp.盘中异动 急速上涨5.17%报8.03美元
Anavex Life Sciences Corp.盘中异动 股价大涨5.05%
市场透视 · 11-04
Anavex Life Sciences Corp.盘中异动 股价大涨5.05%
Anavex Life Sciences Corp.盘中异动 早盘股价大涨5.14%
市场透视 · 11-01
Anavex Life Sciences Corp.盘中异动 早盘股价大涨5.14%
公司概况
公司名称:
Anavex Life Sciences Corp.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Anavex Life Sciences Corp.成立于2004年1月23日,位于内华达州。是一家临床阶段的生物制药公司,致力于开发差异化疗法,将精准医学应用于高度未满足需求的中枢神经系统(CNS)疾病。该公司目前有两个核心计划和两个种子计划。该公司的核心计划处于神经退行性疾病和神经发育疾病的临床和临床前开发的各个阶段。
发行价格:
--
{"stockData":{"symbol":"AVXL","market":"US","secType":"STK","nameCN":"Anavex Life Sciences Corp.","latestPrice":11.2937,"timestamp":1734979935101,"preClose":8.63,"halted":0,"volume":5610727,"delay":0,"floatShares":82205887,"shares":84795517,"eps":-0.501751,"marketStatus":"交易中","marketStatusCode":2,"change":2.6637,"latestTime":"12-23 13:52:15 EST","open":8.9699,"high":11.5,"low":8.92,"amount":60395284.941931,"amplitude":0.298957,"askPrice":11.3,"askSize":100,"bidPrice":11.27,"bidSize":460,"shortable":3,"etf":0,"ttmEps":-0.501751,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1734987600000},"adr":0,"adjPreClose":8.63,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":8.99,"preClose":8.63,"latestTime":"09:29 EST","volume":155262,"amount":1395975.081366,"timestamp":1734964179094},"postHourTrading":{"tag":"盘后","latestPrice":8.5008,"preClose":8.63,"latestTime":"19:55 EST","volume":154736,"amount":1334894.3931,"timestamp":1734742515642},"volumeRatio":5.269322,"impliedVol":1.2217,"impliedVolPercentile":0.8685},"requestUrl":"/m/hq/s/AVXL/wiki","defaultTab":"wiki","newsList":[{"id":"1175502803","title":"Anavex Life Sciences 2024年第四季度GAAP每股收益$(0.14),优于预期$(0.16);现金为1.322亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1175502803","media":"财报速递","labels":["express"],"top":1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175502803?lang=zh_cn&edition=full","pubTime":"2024-12-23 20:34","pubTimestamp":1734957262,"startTime":"0","endTime":"0","summary":"Anavex Life Sciences 报告季度每股亏损$,优于分析师普遍预期的$,超出12.5%。这是较去年同期每股亏损$减少了16.67%。以上内容来自Benzinga Earnings专栏,原文如下:Anavex Life Sciences reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 12.5 percent. This is a 16.67 percent decrease over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Anavex Life Sciences 2024年第四季度GAAP每股收益$(0.14),优于预期$(0.16);现金为1.322亿美元","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVXL"],"gpt_icon":0},{"id":"2493661637","title":"Anavex Life Sciences Corp.盘中异动 早盘快速拉升17.61%报10.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493661637","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493661637?lang=zh_cn&edition=full","pubTime":"2024-12-23 22:35","pubTimestamp":1734964508,"startTime":"0","endTime":"0","summary":"北京时间2024年12月23日22时35分,Anavex Life Sciences Corp.股票出现波动,股价大幅上涨17.61%。截至发稿,该股报10.15美元/股,成交量61.7637万股,换手率0.73%,振幅15.99%。Anavex Life Sciences Corp.股票所在的生物技术行业中,整体涨幅为0.14%。Anavex Life Sciences Corp.公司简介:Anavex Life Sciences Corp 是一家临床阶段的生物制药公司,致力于通过将精准医学应用于具有高度未满足需求的中枢神经系统疾病来开发差异化疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223223508a2050b9b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223223508a2050b9b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVXL"],"gpt_icon":0},{"id":"1107716216","title":"异动解读 | Anavex Life Sciences财报亏损好于预期 股价盘中大涨15.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=1107716216","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107716216?lang=zh_cn&edition=full","pubTime":"2024-12-23 22:34","pubTimestamp":1734964464,"startTime":"0","endTime":"0","summary":"神经退行性疾病生物制药公司Anavex Life Sciences周一盘中出现大涨行情,股价上涨15.87%,引起了市场广泛关注。财报显示,Anavex Life Sciences本季度每股亏损0.14美元,好于分析师此前预期的0.16美元亏损水平,而且亏损幅度也较上年同期有所下降。这一超预期的业绩让投资者看好公司目前的业务状况以及未来前景。作为一家专注于研发治疗神经退行性疾病新药的生物制药企业,Anavex Life Sciences在阿尔茨海默病、帕金森等疾病的研发管线中已有多款潜在新药,现金储备充足,公司前景令人期待。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["AVXL"],"gpt_icon":0},{"id":"1113045402","title":"异动解读 | Anavex Life Sciences盘前大涨9.85%,财报亏损好于预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1113045402","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113045402?lang=zh_cn&edition=full","pubTime":"2024-12-23 20:36","pubTimestamp":1734957381,"startTime":"0","endTime":"0","summary":"据报道,生物科技公司Anavex Life Sciences Corp. 在盘前交易中出现大涨行情,股价上涨9.85%。这种反常走势引起了广泛关注。分析认为,主要原因是该公司公布了2024年第四季度的季度财报。数据显示,Anavex Life Sciences本季度每股亏损为0.14美元,超出分析师预期的0.16美元亏损水平。与去年同期相比,公司亏损有所下降。这一超预期的数据令投资者看好公司目前的业务状况和未来前景。Anavex Life Sciences是一家生物制药公司,专注于治疗阿尔茨海默病、帕金森等神经退行性疾病的药物研发。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["AVXL"],"gpt_icon":0},{"id":"2492153145","title":"Anavex Life Sciences Corp.盘中异动 下午盘股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492153145","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492153145?lang=zh_cn&edition=full","pubTime":"2024-12-19 03:53","pubTimestamp":1734551635,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日03时53分,Anavex Life Sciences Corp.股票出现波动,股价急速下跌5.10%。截至发稿,该股报8.74美元/股,成交量60.2504万股,换手率0.71%,振幅7.06%。Anavex Life Sciences Corp.股票所在的生物技术行业中,整体跌幅为1.90%。Anavex Life Sciences Corp.公司简介:Anavex Life Sciences Corp 是一家临床阶段的生物制药公司,致力于通过将精准医学应用于具有高度未满足需求的中枢神经系统疾病来开发差异化疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121903535595ea5990&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121903535595ea5990&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVXL"],"gpt_icon":0},{"id":"2491690591","title":"Anavex Life Sciences Corp.盘中异动 早盘股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491690591","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491690591?lang=zh_cn&edition=full","pubTime":"2024-12-16 23:05","pubTimestamp":1734361537,"startTime":"0","endTime":"0","summary":"北京时间2024年12月16日23时05分,Anavex Life Sciences Corp.股票出现异动,股价急速上涨5.08%。Anavex Life Sciences Corp.股票所在的生物技术行业中,整体涨幅为0.69%。Anavex Life Sciences Corp.公司简介:Anavex Life Sciences Corp 是一家临床阶段的生物制药公司,致力于通过将精准医学应用于具有高度未满足需求的中枢神经系统疾病来开发差异化疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121623053795ea13e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121623053795ea13e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVXL"],"gpt_icon":0},{"id":"2491757553","title":"Anavex Life Sciences Corp.盘中异动 早盘股价大涨5.12%报8.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491757553","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491757553?lang=zh_cn&edition=full","pubTime":"2024-12-13 22:33","pubTimestamp":1734100427,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日22时33分,Anavex Life Sciences Corp.股票出现波动,股价快速上涨5.12%。截至发稿,该股报8.73美元/股,成交量11.1647万股,换手率0.13%,振幅4.70%。Anavex Life Sciences Corp.股票所在的生物技术行业中,整体跌幅为0.13%。Anavex Life Sciences Corp.公司简介:Anavex Life Sciences Corp 是一家临床阶段的生物制药公司,致力于通过将精准医学应用于具有高度未满足需求的中枢神经系统疾病来开发差异化疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121322334795e976bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121322334795e976bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVXL","BK4139"],"gpt_icon":0},{"id":"2490145710","title":"Anavex Life Sciences Corp.盘中异动 股价大涨5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490145710","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490145710?lang=zh_cn&edition=full","pubTime":"2024-12-10 23:07","pubTimestamp":1733843228,"startTime":"0","endTime":"0","summary":"北京时间2024年12月10日23时07分,Anavex Life Sciences Corp.股票出现异动,股价大幅上涨5.18%。Anavex Life Sciences Corp.股票所在的生物技术行业中,整体跌幅为1.22%。Anavex Life Sciences Corp.公司简介:Anavex Life Sciences Corp 是一家临床阶段的生物制药公司,致力于通过将精准医学应用于具有高度未满足需求的中枢神经系统疾病来开发差异化疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210230708984b0de1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210230708984b0de1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVXL"],"gpt_icon":0},{"id":"2489393982","title":"Anavex Life Sciences Corp.盘中异动 早盘股价大涨5.26%报8.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489393982","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489393982?lang=zh_cn&edition=full","pubTime":"2024-12-06 22:32","pubTimestamp":1733495579,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日22时32分,Anavex Life Sciences Corp.股票出现异动,股价大幅拉升5.26%。截至发稿,该股报8.00美元/股,成交量8.7447万股,换手率0.10%,振幅2.37%。Anavex Life Sciences Corp.股票所在的生物技术行业中,整体涨幅为0.22%。Anavex Life Sciences Corp.公司简介:Anavex Life Sciences Corp 是一家临床阶段的生物制药公司,致力于通过将精准医学应用于具有高度未满足需求的中枢神经系统疾病来开发差异化疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120622325998e5e17c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120622325998e5e17c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVXL"],"gpt_icon":0},{"id":"2488949919","title":"Anavex Life Sciences Corp.盘中异动 股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488949919","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488949919?lang=zh_cn&edition=full","pubTime":"2024-12-03 23:00","pubTimestamp":1733238000,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日23时00分,Anavex Life Sciences Corp.股票出现异动,股价快速下跌5.04%。Anavex Life Sciences Corp.股票所在的生物技术行业中,整体跌幅为0.43%。Anavex Life Sciences Corp.公司简介:Anavex Life Sciences Corp 是一家临床阶段的生物制药公司,致力于通过将精准医学应用于具有高度未满足需求的中枢神经系统疾病来开发差异化疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120323000098e51d3c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120323000098e51d3c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVXL"],"gpt_icon":0},{"id":"2488677427","title":"Anavex Life Sciences Corp.盘中异动 早盘股价大涨5.23%报9.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488677427","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488677427?lang=zh_cn&edition=full","pubTime":"2024-12-02 22:48","pubTimestamp":1733150880,"startTime":"0","endTime":"0","summary":"北京时间2024年12月02日22时48分,Anavex Life Sciences Corp.股票出现异动,股价急速拉升5.23%。截至发稿,该股报9.96美元/股,成交量16.2537万股,换手率0.19%,振幅5.50%。Anavex Life Sciences Corp.股票所在的生物技术行业中,整体涨幅为0.09%。Anavex Life Sciences Corp.公司简介:Anavex Life Sciences Corp 是一家临床阶段的生物制药公司,致力于通过将精准医学应用于具有高度未满足需求的中枢神经系统疾病来开发差异化疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202224800a266a256&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202224800a266a256&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVXL"],"gpt_icon":0},{"id":"2487565861","title":"Anavex Life Sciences Corp.盘中异动 早盘股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2487565861","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487565861?lang=zh_cn&edition=full","pubTime":"2024-11-29 23:10","pubTimestamp":1732893018,"startTime":"0","endTime":"0","summary":"北京时间2024年11月29日23时10分,Anavex Life Sciences Corp.股票出现波动,股价大幅上涨5.04%。截至发稿,该股报9.49美元/股,成交量28.4745万股,换手率0.34%,振幅6.37%。Anavex Life Sciences Corp.股票所在的生物技术行业中,整体跌幅为0.25%。Anavex Life Sciences Corp.公司简介:Anavex Life Sciences Corp 是一家临床阶段的生物制药公司,致力于通过将精准医学应用于具有高度未满足需求的中枢神经系统疾病来开发差异化疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129231019971aa89a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129231019971aa89a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVXL"],"gpt_icon":0},{"id":"2486908026","title":"Anavex Life Sciences Corp.盘中异动 早盘快速拉升6.92%报9.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486908026","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486908026?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:32","pubTimestamp":1732545133,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时32分,Anavex Life Sciences Corp.股票出现波动,股价大幅上涨6.92%。截至发稿,该股报9.74美元/股,成交量13.9628万股,换手率0.16%,振幅2.70%。Anavex Life Sciences Corp.股票所在的生物技术行业中,整体涨幅为0.97%。Anavex Life Sciences Corp.公司简介:Anavex Life Sciences Corp 是一家临床阶段的生物制药公司,致力于通过将精准医学应用于具有高度未满足需求的中枢神经系统疾病来开发差异化疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223213a2548c7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223213a2548c7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVXL","BK4139"],"gpt_icon":0},{"id":"2484927583","title":"Anavex Life Sciences Corp.盘中异动 股价大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484927583","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484927583?lang=zh_cn&edition=full","pubTime":"2024-11-20 00:37","pubTimestamp":1732034265,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日00时37分,Anavex Life Sciences Corp.股票出现波动,股价急速拉升5.10%。Anavex Life Sciences Corp.股票所在的生物技术行业中,整体跌幅为0.81%。Anavex Life Sciences Corp.公司简介:Anavex Life Sciences Corp 是一家临床阶段的生物制药公司,致力于通过将精准医学应用于具有高度未满足需求的中枢神经系统疾病来开发差异化疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120003745abcfa131&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120003745abcfa131&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVXL"],"gpt_icon":0},{"id":"2483004623","title":"Anavex Life Sciences Corp.盘中异动 股价大跌5.92%报7.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483004623","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483004623?lang=zh_cn&edition=full","pubTime":"2024-11-16 01:35","pubTimestamp":1731692148,"startTime":"0","endTime":"0","summary":"北京时间2024年11月16日01时35分,Anavex Life Sciences Corp.股票出现异动,股价急速跳水5.92%。截至发稿,该股报7.56美元/股,成交量93.3212万股,换手率1.10%,振幅5.10%。Anavex Life Sciences Corp.股票所在的生物技术行业中,整体跌幅为3.65%。Anavex Life Sciences Corp.公司简介:Anavex Life Sciences Corp 是一家临床阶段的生物制药公司,致力于通过将精准医学应用于具有高度未满足需求的中枢神经系统疾病来开发差异化疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116013548abc5454c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116013548abc5454c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVXL"],"gpt_icon":0},{"id":"2483383083","title":"Anavex Life Sciences Corp.盘中异动 早盘急速下跌5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483383083","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483383083?lang=zh_cn&edition=full","pubTime":"2024-11-14 23:50","pubTimestamp":1731599454,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日23时50分,Anavex Life Sciences Corp.股票出现异动,股价快速下跌5.23%。Anavex Life Sciences Corp.股票所在的生物技术行业中,整体跌幅为0.45%。Anavex Life Sciences Corp.公司简介:Anavex Life Sciences Corp 是一家临床阶段的生物制药公司,致力于通过将精准医学应用于具有高度未满足需求的中枢神经系统疾病来开发差异化疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114235054abc18411&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114235054abc18411&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVXL"],"gpt_icon":0},{"id":"2482735851","title":"Anavex Life Sciences Corp.盘中异动 早盘股价大涨6.06%报9.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482735851","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482735851?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:32","pubTimestamp":1731335531,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时32分,Anavex Life Sciences Corp.股票出现异动,股价急速拉升6.06%。截至发稿,该股报9.80美元/股,成交量18.5893万股,换手率0.22%,振幅2.02%。Anavex Life Sciences Corp.股票所在的生物技术行业中,整体跌幅为0.13%。Anavex Life Sciences Corp.公司简介:Anavex Life Sciences Corp 是一家临床阶段的生物制药公司,致力于通过将精准医学应用于具有高度未满足需求的中枢神经系统疾病来开发差异化疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223211971a5aeb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223211971a5aeb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVXL"],"gpt_icon":0},{"id":"2481548812","title":"Anavex Life Sciences Corp.盘中异动 急速上涨5.17%报8.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481548812","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481548812?lang=zh_cn&edition=full","pubTime":"2024-11-08 23:32","pubTimestamp":1731079963,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日23时32分,Anavex Life Sciences Corp.股票出现波动,股价快速拉升5.17%。截至发稿,该股报8.03美元/股,成交量60.2495万股,换手率0.71%,振幅5.76%。Anavex Life Sciences Corp.股票所在的生物技术行业中,整体涨幅为0.78%。Anavex Life Sciences Corp.公司简介:Anavex Life Sciences Corp 是一家临床阶段的生物制药公司,致力于通过将精准医学应用于具有高度未满足需求的中枢神经系统疾病来开发差异化疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108233243a224e692&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108233243a224e692&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVXL"],"gpt_icon":0},{"id":"2480580694","title":"Anavex Life Sciences Corp.盘中异动 股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480580694","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480580694?lang=zh_cn&edition=full","pubTime":"2024-11-04 23:14","pubTimestamp":1730733261,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日23时14分,Anavex Life Sciences Corp.股票出现波动,股价快速上涨5.05%。截至发稿,该股报7.18美元/股,成交量35.7427万股,换手率0.42%,振幅7.68%。Anavex Life Sciences Corp.股票所在的生物技术行业中,整体涨幅为0.08%。Anavex Life Sciences Corp.公司简介:Anavex Life Sciences Corp 是一家临床阶段的生物制药公司,致力于通过将精准医学应用于具有高度未满足需求的中枢神经系统疾病来开发差异化疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104231421ab9ed179&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104231421ab9ed179&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVXL"],"gpt_icon":0},{"id":"2480882322","title":"Anavex Life Sciences Corp.盘中异动 早盘股价大涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480882322","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480882322?lang=zh_cn&edition=full","pubTime":"2024-11-01 21:55","pubTimestamp":1730469331,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日21时55分,Anavex Life Sciences Corp.股票出现异动,股价急速拉升5.14%。截至发稿,该股报6.96美元/股,成交量23.0478万股,换手率0.27%,振幅5.73%。Anavex Life Sciences Corp.股票所在的生物技术行业中,整体涨幅为0.71%。Anavex Life Sciences Corp.公司简介:Anavex Life Sciences Corp 是一家临床阶段的生物制药公司,致力于通过将精准医学应用于具有高度未满足需求的中枢神经系统疾病来开发差异化疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101215531ab92d910&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101215531ab92d910&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVXL"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.anavex.com","stockEarnings":[{"period":"1week","weight":0.0201},{"period":"1month","weight":0.0183},{"period":"3month","weight":0.5301},{"period":"6month","weight":1.1152},{"period":"1year","weight":-0.0137},{"period":"ytd","weight":-0.073}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Anavex Life Sciences Corp.成立于2004年1月23日,位于内华达州。是一家临床阶段的生物制药公司,致力于开发差异化疗法,将精准医学应用于高度未满足需求的中枢神经系统(CNS)疾病。该公司目前有两个核心计划和两个种子计划。该公司的核心计划处于神经退行性疾病和神经发育疾病的临床和临床前开发的各个阶段。","yearOnYearQuotes":[{"month":1,"riseRate":0.555556,"avgChangeRate":-0.035298},{"month":2,"riseRate":0.555556,"avgChangeRate":0.165719},{"month":3,"riseRate":0.555556,"avgChangeRate":0.075509},{"month":4,"riseRate":0.222222,"avgChangeRate":-0.092651},{"month":5,"riseRate":0.777778,"avgChangeRate":0.060811},{"month":6,"riseRate":0.666667,"avgChangeRate":0.162785},{"month":7,"riseRate":0.444444,"avgChangeRate":-0.058369},{"month":8,"riseRate":0.444444,"avgChangeRate":-0.024515},{"month":9,"riseRate":0.555556,"avgChangeRate":0.020112},{"month":10,"riseRate":0.555556,"avgChangeRate":0.007649},{"month":11,"riseRate":0.4,"avgChangeRate":0.020111},{"month":12,"riseRate":0.4,"avgChangeRate":-0.043755}],"exchange":"NASDAQ","name":"Anavex Life Sciences Corp.","nameEN":"Anavex Life Sciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Anavex Life Sciences Corp.(AVXL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Anavex Life Sciences Corp.(AVXL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Anavex Life Sciences Corp.,AVXL,Anavex Life Sciences Corp.股票,Anavex Life Sciences Corp.股票老虎,Anavex Life Sciences Corp.股票老虎国际,Anavex Life Sciences Corp.行情,Anavex Life Sciences Corp.股票行情,Anavex Life Sciences Corp.股价,Anavex Life Sciences Corp.股市,Anavex Life Sciences Corp.股票价格,Anavex Life Sciences Corp.股票交易,Anavex Life Sciences Corp.股票购买,Anavex Life Sciences Corp.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Anavex Life Sciences Corp.(AVXL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Anavex Life Sciences Corp.(AVXL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}